MKM Partners maintains a 'Buy' on DSW Inc. (DSW); Raising Numbers As Top-line Momentum Looks Sustainable
Tweet Send to a FriendGet Alerts DSW Hot Sheet
Price: $69.56 +0.74%
Rating Summary:
12 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 35 | New: 23
Rating Summary:
12 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 35 | New: 23
Trade DSW Now!
MKM Partners maintains a 'Buy' on DSW Inc. (NYSE: DSW) price target of $75.00 (from $65.00).
Analyst, Patrick McKeever, said, "We are raising our FY12 EPS estimate from 3.30 to $3.35 vs. reaffirmed guidance of $3.25-$3.40 and our FY13 EPS estimate from $3.70 to $3.75. We continue to expect very strong 4Q12 EPS given a lack of pre-opening expenses, the early ramp of 26 new stores to be opened in 3Q12, the cycling of easier merchandise margin comparisons and the benefit of a 53rd week in the reporting calendar."
For an analyst ratings summary and ratings history on DSW Inc. click here. For more ratings news on DSW Inc. click here.
Shares of DSW Inc. closed at $64.50 yesterday, with a 52 week range of $37.29-$64.90.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Analyst, Patrick McKeever, said, "We are raising our FY12 EPS estimate from 3.30 to $3.35 vs. reaffirmed guidance of $3.25-$3.40 and our FY13 EPS estimate from $3.70 to $3.75. We continue to expect very strong 4Q12 EPS given a lack of pre-opening expenses, the early ramp of 26 new stores to be opened in 3Q12, the cycling of easier merchandise margin comparisons and the benefit of a 53rd week in the reporting calendar."
For an analyst ratings summary and ratings history on DSW Inc. click here. For more ratings news on DSW Inc. click here.
Shares of DSW Inc. closed at $64.50 yesterday, with a 52 week range of $37.29-$64.90.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Morgan Stanley Says Tesla (TSLA) 'Top Pick in U.S. Autos'
- Supernus (SUPN) PT Trimmed at Jefferies, But Survey Shows Significant Market Opportunity
- Goldman Sees Blockbuster Potential for Bristol-Myers Squibb's (BMY) Nivolumab (PD-1)
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT Change
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
